Oral Sodium Blood Pressure in Normal Weight, Overweight and Obese Volunteers
NCT ID: NCT01532401
Last Updated: 2016-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
51 participants
INTERVENTIONAL
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participating subjects will have a first visit with blood pressure measurement and a blood sample. In two consecutive phases of one week, subjects will receive 12 pills of sodium (6 grams) or corresponding placebo. Blood pressure will be measured at the end of each phase.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison on Blood Pressure Effect of an Equivalent Sodium Intake, With Different Nature, for Hypertensive Subjects
NCT05108402
Comparative Evaluation of the Effect on Blood Pressure of an Equivalent Content of Sodium in the Form of Bicarbonate of Sodium and in the Form of Sodium Chloride, on "Sensitive Sodium" Subjects
NCT02561325
Hypertension Prevention Trial (HPT) Feasibility Study
NCT00000501
The Natriuretic Peptide Response to Saline Infusion
NCT04223531
The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults
NCT04074941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chlorure de sodium
sodium chloride
sodium chloride 500mg
Methylcellulose
Methylcellulose crystalline
Methylcellulose 37 ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sodium chloride
sodium chloride 500mg
Methylcellulose crystalline
Methylcellulose 37 ml
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-45 for adults and 6-8 for children
Exclusion Criteria
* Chronic condition affecting blood pressure
* Diabetes (known to affect blood pressure sensitivity to salt)
* Hypertension
6 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poitiers University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samy HADJADJ, MD
Role: PRINCIPAL_INVESTIGATOR
CHU DE POITIERS-Service d'endocrinologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Poitiers University Hospital
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PLADSEL 2010-023410-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.